药 物 回 收
|
| |
| Canada: Recall: JAMP Pentoxifylline SR 400mg: Affected lot may contain Sitagliptin 100mg tablets (English only) |
| |
Health Canada announces that JAMP Pharma Corporation is recalling one lot of JAMP Pentoxifylline SR 400mg Tablet (Extended-Release) (lot number: P3824001F) from retailers because the affected lot may contain Sitagliptin 100mg tablets.
JAMP Pentoxifylline SR is indicated for symptomatic treatment of patients with chronic occlusive peripheral vascular disorders of the extremities.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-pentoxifylline-sr-400mg-affected-lot-may-contain-sitagliptin-100mg-tablets
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, May 6, 2025
Issued at HKT 16:30
|
| |
